Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý
Also in the Knowledge Center
/ Nov 16, 2020
Inverse Gas Chromatography (IGC) of Pharmaceutical Powders: Harnessing the Power of Adhesion-Cohesion Forces to Improve Pharmaceutical Development
Read more
Scientific Article
Scientific Article
Scientific Article